INTERNATIONAL PATENT: LANTERN PHARMA INC. FILES APPLICATION FOR "SYSTEM AND METHOD FOR IMPROVING PREDICTIVE MODELING OF OUTCOMES BASED ON CTDNA PROFILE"

GENEVA, March 25 -- LANTERN PHARMA INC. (1920 McKinney Ave., 7th FloorDallas, Texas 75201) filed a patent application (PCT/US2025/046268) for "SYSTEM AND METHOD FOR IMPROVING PREDICTIVE MODELING OF OUTCOMES BASED ON ctDNA PROFILE" on Sep 12, 2025. With publication no. WO/2026/060310, the details related to the patent application was published on Mar 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MCDERMOTT, Joseph (1920 McKinney Ave., 7th FloorDallas, Texas 75201)

Abstract: A system and method for improving predictive modeling of patient outcomes by transforming ctDNA-linked genomic dat...